IMV Inc. Undergoes Drastic Shifts to Attain High Value
IMV Inc. (NASDAQ: IMV) is a biotech player which describes itself as an ‘immuno-ocology company’. It has recently undertaken a number of major restructuring initiatives which it claims is part of a wider value-creating strategy. IMV Downsizes a Third of its Total Strength IMV is presently cutting down its staff size by 33%, in lieu …
IMV Inc. Undergoes Drastic Shifts to Attain High Value Read More »